# Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia

> **NCT00002148** · PHASE1 · COMPLETED · sponsor: **University of Rochester** · enrollment: 30 (—)

## Conditions studied

- Cognitive Disorders
- HIV Infections

## Interventions

- **DRUG:** OPC 14117

## Key facts

- **NCT ID:** NCT00002148
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002148, "Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*